Cytokinetics to Host Research and Development Day on Wednesday, December …

Published November 28, 2012

Cytokinetics to Host Research and Development Day on Wednesday, December …

Filed under: drug rehab treatment ny

Cytokinetics' lead drug candidate from its cardiac muscle contractility program, omecamtiv mecarbil, is in Phase II clinical development for the potential treatment of heart failure. Amgen Inc. holds an exclusive license worldwide (excluding Japan) to …
Read more on Reuters

Curemark Announces New Patent Covering Treatment Of Drug And Alcohol …

Filed under: drug rehab treatment ny

RYE, N.Y., Nov. 27, 2012 — /PRNewswire/ — Curemark announced today that it has been granted patent #8,318,158 for its proprietary technology CM-1212 for the treatment of individuals with drug and alcohol addiction. This is the second in a series of …
Read more on Sacramento Bee

Deaths more common on popular heart drug: study

Filed under: drug rehab treatment ny

NEW YORK (Reuters Health) – People with a common type of abnormal heart rhythm were more likely to die within several years if they had been prescribed digoxin, a drug used to help control abnormal heart rates, in a new analysis. The research involved …
Read more on Reuters